저자의 연구 키워드

저자의 연구 키워드

#.

#1 remains unchanged

#3 have been updated

#4 new key questions have been introduced These changes are summarized in Tables 1 and 2 For each question

#Adenocarcinoma

#Adjuvant

#Age

#all established through expert consensus (Table 3)

#an updated edition that builds on the foundational work of version 50 The updated guidelines integrate newly published studies and reassess existing evidence to provide the most up-to-date recommendations Among the original 5 key questions

#Anatomic variation

#and 1 has been removed due to insufficient clinical evidence In addition

#Atypical squamous cells of the cervix

#between 2023 and 2024

#Blood platelets

#CA-125 antigen

#Cancer Screening Tests

#Cervical intraepithelial neoplasia

#Cervical neoplasms

#Chemoradiotherapy

#Chemotherapy

#Chk1 inhibitor

#Classification

#Clear Cell

#Clear cell adenocarcinoma

#Cold coagulation

#Colposcopy

#Conization

#culminating in the release of the final version The selection of the key questions and the systematic reviews were based on data available up to December 2022 However

#Early Detection of Cancer

#Endometrial Cancer

#Endometrial Neoplasm

#Endometrial Neoplasms

#Endometriosis

#Epidemiologic studies

#Epithelial ovarian cancer

#focusing on 5 key clinical questions Each question was explored through systematic reviews and meta-analyses

#forming the basis for drafting evidence-based recommendations with clearly defined levels and grades of evidence These drafts under went further refinement through consultations with relevant academic societies and public hearings

#Gastrointestinal tract

#High-Grade Squamous Intraepithelial Lesions

#Human papillomavirus DNA tests

#Hyperthermic Intraperitoneal Chemotherapy

#Hysterectomy

#Immune Checkpoint Inhibitor

#Immune Checkpoint Inhibitors

#Incidence

#Inhibitor

#Keap1

#Keywords: Polymerase Chain Reaction

#Laparoscopy

#Laparotomy

#Leiomyosarcoma

#Loop electrosurgical excisional procedure

#Lymph node metastasis

#Lymphocytes

#Minimally Invasive Surgical Procedures

#Mir vetuximab Soravtansine

#Neutrophils

#Nrf2

#Ovarian cancer

#Ovarian Neopla는

#Ovarian neoplasms

#Ovary

#Papanicolaou Test

#Papillary

#PARP inhibitor

#PARP Inhibitors

#Poly(ADP-ribose) Polymerase (PARP) Inhibitor

#Practice Guideline

#Prognosis

#Rad51

#Radiotherapy

#recommendation was formulated with corresponding level of evidence and grade of recommendation

#Resveratrol

#Risk-educing Salpingo-oophorectomy

#Sentinel Lymph Node

#Sentinel Lymph Node Biopsy

#Stage reassignment

#substantial findings from large-scale clinical trials and new advancements in cer vical cancer research emerged To incorporate these developments

#Supraclavicular lymph node metastasis

#Sur vival

#Surger y

#Surgical spillage

#Survival rate

#the KSGO has released the Clinical Practice Guidelines for Cer vical Cancer version 51

#Trabectedin

#Trastuzumab

#Trastuzumab Deruxtecan

#Urinary tract

#Uterine Cer vical Neopla는

#Uterine Cer vical Neoplasms The Korean Society of Gynecologic Oncology (KSGO) announced the fifth version of its clinical practice guidelines for the management of cer vical cancer in March 2024 These guidelines were developed to reflect the latest insights and address critical contemporar y issues in cer vical cancer care

#Uterine cervical dysplasia

#Uterine Cervical Neoplasms

#Wine